Cancer is swiftly becoming a major health issue in India, affecting both urban and rural populations due to various factors.

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Yashoda Hospitals hosts Bronchus 2025 Conference in Hyderabad, uniting global experts to address lung cancer challenges.

Biopharmaceutical giant AstraZeneca has announced it is introducing advanced diagnostic testing for lung cancer in Kenya and ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

As monotherapy for treatment of adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations, after failure of platinum-based therapy.

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...